MedAssets Given Average Recommendation of “Hold” by Brokerages (NASDAQ:MDAS)
Shares of MedAssets (NASDAQ:MDAS) have received a consensus recommendation of “Hold” from the twenty-three ratings firms that are presently covering the company, Stock Ratings Network.com reports. Twelve investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $25.40.
MedAssets (NASDAQ:MDAS) traded down 5.51% during mid-day trading on Friday, hitting $20.0701. The stock had a trading volume of 329,185 shares. MedAssets has a 52-week low of $19.38 and a 52-week high of $26.58. The stock’s 50-day moving average is $23.20 and its 200-day moving average is $23.17. The company has a market cap of $1.206 billion and a price-to-earnings ratio of 45.19.
MedAssets (NASDAQ:MDAS) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.29 by $0.01. The company had revenue of $175.42 million for the quarter, compared to the consensus estimate of $175.70 million. During the same quarter in the prior year, the company posted $0.30 earnings per share. The company’s quarterly revenue was up 2.7% on a year-over-year basis. Analysts expect that MedAssets will post $1.35 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Raymond James reiterated an “outperform” rating on shares of MedAssets in a research note on Thursday. They now have a $27.50 price target on the stock, up previously from $25.00. Separately, analysts at Citigroup Inc. downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 29th. They now have a $26.00 price target on the stock, down previously from $28.00. Finally, analysts at Bank of America downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 22nd. They now have a $24.00 price target on the stock, down previously from $25.00.
MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.